Perioperative Administration of Desmopressin to Subjects With Breast Cancer: A Phase IIa, Dose-Escalation Study
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2015
At a glance
- Drugs Desmopressin (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors Elea
- 10 Jun 2017 Biomarkers information updated
- 29 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Mar 2015 Planned End Date changed to 1 Jun 2015, according to ClinicalTrials.gov record.